Login
Description
Why buy Flavedon (Trimetazidine) for angina pectoris?
The active ingredient of this drug can prevent angina attack without affecting the heart rate and blood pressure. Flavedon is effective angina pectoris. It is used in patients who do not respond well to first-line anti-anginal drugs.
How does Flavedon (Trimetazidine) work?
Flavedon contains Trimetazidine as an active ingredient. It is used in combination with other drugs in treating angina pectoris. Flavedon works by producing a good supply of oxygen for the heart cells.
How to use Flavedon (Trimetazidine)?
Flavedon is in tablet form that you need to take by mouth. Take Flavedon exactly as directed by your doctor or follow the instructions found on the product label. Your dosage is based on the following:
- Your age
- Your condition
- The severity of your condition
- Your other health conditions
The usual dose of Flavedon 35mg is 1 tablet in the morning and evening. You should swallow the tablet whole with a glass of water at meal times. In case of missed dosed, continue with your treatment. Do not double your dose for the missed one.
What are the side effects of Flavedon (Trimetazidine)?
The following are a list of possible side effects of Flavedon:
- Vomiting
- Constipation
- Diarrhea
- Inflammation of liver
- Dizziness
- Low blood pressure with a change of position
- Inflammation of liver
- Itching of skin
- Nausea
- Allergic skin reactions
- Sleep disorders
Warning and Precautions
Consult your doctor if:
- You have kidney and liver problems
- You are currently under medications
- You have allergies or are allergic to Trimetazidine
- You have pre-existing diseases
- You are pregnant or breastfeeding
Other things to consider are:
- This drug may make you feel dizzy. Do not drive or operate heavy machinery
- Flavedon may interact with other drugs. Using other drugs and OTC at the same time can affect the efficacy of this drug.
- Do not use this drug if you are hypersensitive
- Avoid alcohol and grapefruit juice.
Reviews
There are no reviews yet.